JPRN-UMIN000015759招募中未知
Effect of SGLT2 inhibitor on lactic acid,ketone bodies,glucagon in type 2 diabetes mellitus patients. - Effect of SGLT2 inhibitor on lactic acid,ketone bodies,glucagon in type 2 diabetes mellitus patients.
Department of Endoclinology, Gifu University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2014年12月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type 1 diabetes mellitus. 2) having diabetic ketoacidosis, nonketotic hyperosmolar coma, infection. 3) being pregnant or possibly pregnant.
研究者
相似试验
招募中
1 期
SGLTi, Hepatic Glucose Production and KetogenesisType 2 DiabetesNCT05960656The University of Texas Health Science Center at San Antonio30
已完成
不适用
Ketoacidosis in type 2 diabetics on SGLT-2 inhibitorsType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN96827601Southend University Hospital NHS Foundation Trust60
进行中（未招募）
1 期
The REFORM TrialType 2 diabetes and Heart FailureEUCTR2014-002742-42-GBniversity of Dundee/ NHS Tayside56
尚未招募
2 期
Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF)Heart Failure with Reduced Ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12621000187842The Alfred Hospital36
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16